Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sorrento Therapeutics Inc SRNE

Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing a portfolio of next-generation treatments for cancer, infectious diseases and pain. It is also developing Resiniferatoxin (RTX), a naturally occurring non-opioid ultra-potent transient receptor potential vanilloid-1 agonist. The Company’s proprietary fully human G-MAB... see more

GREY:SRNE - Post Discussion

Sorrento Therapeutics Inc > Latest discussions
View:
Post by TheeRook on Jan 21, 2021 3:57am

Latest discussions

From JD

Have a listen to today's discussion with Dr. Henry Ji.


My highlights from in his words. Slightly Paraphrase.

• Abivertinib now in 40 patients for Covid19. "So Happy with the things we seen", "We seen the discharge rate from the hospital, from the ICU"

• Stem Cells, for lung damage

• COVI STIX, " We see the demand for this product is huge", We see with FDA approval after testing with STIX you take COVI DROPS nasal right after and stop the virus in their tracks.

• Speaks on Eli Lily and Regeneron IV push, being not as good as SRNE COVI AMG, does high potency and quick push in 40 min. And the virus to date has not show to escape AMG, dealing with mutations.

A few more things mentioned that you must listen. Very good updates here that we have not had yet.

Hint; at 13:50 min mark he mentions how SRNE Abivertinib Cytokine storm suppressant drug is better the the similar one being used by AstraZeneca which ran into problems in Phase 3. HE mentions that it is much more potent and it can be the one that is saving lives. He must be speaking with confidence based on his Abivertinib trial results like he mentioned in the beginning of the interview.
Comment by TheeRook on Jan 21, 2021 4:13am
From Don I heard the entire presentation...it is worth a listen. I know many are interested in Sorrento's stem cell treatment for severely ill ICU patients. Dr. Ji said the third patient has just been dosed. The first two responded to treatment and have been released from hospital! That's very good news! https://www.webcaster4.com/Webcast/Page/2433/39569 @Gallon333 ...can't agree ...more  
Comment by TheeRook on Jan 21, 2021 4:46am
Sorrento Therapeutics, Inc. (SRNE)  Transcript  on  SA Transcripts https://seekingalpha.com/article/4400090-sorrento-therapeutics-inc-srne-ceo-henry-ji-presents-b-riley-virtual-oncology-conference?utm_source=conferencecalltranscripts.org?part=single Now, the beauty of this one, we are kind of like finishing up the SP-102. That means that will lead to reduce the costs on ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities